RANINasdaqPharmaceutical Preparations

Rani Therapeutics Holdings, Inc. (RANI) earnings date, market-implied expected move, and options open interest by expiry

0.52

0.00 · −0.10%

post 0.55 +5.97%

After hours15:59 ETdelayed

Open0.52Volume697,746Mkt cap$72.0MEPS-0.13

Day0.52 – 0.55100%52-wk0.51 – 2.632%

RANI

Rani Therapeutics Holdings, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

94dRani Therapeutics Appoints Michelle Gilson to Board of Directors

News

Next report

Last report

−0.23%

vs ±35.6% implied · ×0.01

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+9.70%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

67 managers

Top fund weight

0.00%

RANI weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Rani Therapeutics (RANI) is expected to report on Nov 10 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 13 '26confirmed±35.6%▼−0.23%×0.01

quarterimplied−40%0+40%realized×

Q2 FY26±35.6%▼−0.23%×0.01

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 4 close

0.02OI · 3 expiries · Nov 4 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2—Nov 2014d1100%

320−3%Jan 1570d0.181,7550%0.18

20%Apr 16161d0.001,050+7%0.00

ExpiryPutsCallsP/C

Nov 2014d2—1100%0.02

Jan 1570d320−3%1,7550%0.18

Apr 16161d20%1,050+7%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−493.03%as filednet margin · revenue 0.00% QoQ

Revenue$2M0.00%

Gross profit$2M100.00%0.00%

Operating income−$9M−516.86%−5.86%

Pre-tax income−$8M−5.07%

Net income−$8M−493.03%−5.07%

Cost of revenue$0—

Operating expenses$11M+4.87%

Other income$407,000+25.62%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

FOMC ×0.90· ±4.2% vs ±4.6% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±4.2%9 of 24×0.90

CPIconsumer prices±3.9%6 of 11×0.85

PPIproducer prices±3.6%4 of 11×0.79

CPROFcorporate profits±3.5%3 of 12×0.76

GDPgross domestic product±2.6%6 of 20×0.56

NFPjobs report±2.5%6 of 10×0.54

PCEpersonal income & outlays±2.4%10 of 20×0.52

Bar = avg |move| to ±5% · tick = ±4.6% avg day · ×base = |move| ÷ ±4.6% · min 6 releases

Earnings history

EPS -0.04 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.04	—
Q1 FY26	—	-0.04	—
Q3 FY25	—	-0.12	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod